Results
Shukra Pharmaceuticals Q1 Revenue Soars 336% YoY
Board approved un-audited standalone and consolidated financial results for Q1 FY2027, ending June 30, 2026.
Standalone revenue surged to ₹2,352.23 lakhs, with net profit of ₹1,502.98 lakhs, a signifi
